Literature DB >> 12357068

Estimating body fat and lean tissue distribution in hyperthyroidism by dual-energy X-ray absorptiometry.

C Gómez Acotto1, H Niepomniszcze, C A Mautalen.   

Abstract

Body composition (fat mass, lean tissue, and bone mineral content), was determined by dual-energy X-ray absorptiometry (DEXA) at baseline and 6, 12, and 24 mo after treatment of hyperthyroidism. Ten women with Graves' disease were included in this study. Suppressed serum TSH and high total serum thyroxine levels were found in all patients. The patients received antithyroid therapy (methimazol and/or (131) I radioiodine). Lean tissue, bone mass, and body weight increased after 2 yr of euthyroidism. Total body lean mass increased from 32.3+/-3.9 kg to 35.2+/-4.1 kg (p < 0.005). Total lean mass increased from 10.6 +/- 1.8 kg to 11.6 +/- 1.9 kg (p < 0.01) in the legs, from 3.6 +/- 0.8 kg to 4.0 +/- 0.7 kg (p < 0.02) in the arms, and 16.0 +/- 1.6 kg to 17.4+/-1.8 kg (p < 0.005) in the trunk. Total-body fat mass increased from 19.9 +/- 6.6 kg to 21.2 +/- 7.6 kg (ns). At 1-yr, regional analysis disclosed that fat mass had increased in the trunk from 8.9 +/- 2.9 kg to 10.9 +/- 3.9 kg (p < 0.04) and from 2.3 +/- 0.9 kg to 3.2 +/- 1.2 kg in the arms (p < 0.04). After 2 yr of treatment, fat tissue remained unchanged in all of the studied regions. The results obtained herein suggest that, compared to initial values, the treatment of hyperthyroidism restore body weight. This increase is mainly the result of recovery of lean mass, predominantly in the limbs and trunk. This study provides new data on the patterns of change in body composition occurring in hyperthyroid patients during a 24-mo follow-up after attaining euthyroidism.

Entities:  

Mesh:

Year:  2002        PMID: 12357068     DOI: 10.1385/jcd:5:3:305

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  6 in total

1.  Redistribution of body composition in patients with Graves' disease after iodine-131 treatment.

Authors:  L-J Xie; H-J Zhou; J-F Li; F Zhang; F-W Zeng; L-P Qin; Y Chen; H-J Yuan; M-H Cheng
Journal:  Eur J Clin Nutr       Date:  2014-10-29       Impact factor: 4.016

2.  Low serum TSH levels are associated with low values of fat-free mass and body cell mass in the elderly.

Authors:  Till Ittermann; Marcello R P Markus; Martin Bahls; Stephan B Felix; Antje Steveling; Matthias Nauck; Henry Völzke; Marcus Dörr
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

3.  Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves' Disease.

Authors:  Min Joo Kim; Sun Wook Cho; Sumin Choi; Dal Lae Ju; Do Joon Park; Young Joo Park
Journal:  Int J Endocrinol       Date:  2018-05-03       Impact factor: 3.257

4.  Serum Fibroblast Growth Factor 21 Levels in Patients with Hyperthyroidism and its Association with Body Fat Percentage.

Authors:  Aashish Reddy Bande; Pramila Kalra; Mala Dharmalingam; Chitra Selvan; K M Suryanarayana
Journal:  Indian J Endocrinol Metab       Date:  2019 Sep-Oct

5.  Evaluation of Body Weight, Body Condition, and Muscle Condition in Cats with Hyperthyroidism.

Authors:  M E Peterson; C A Castellano; M Rishniw
Journal:  J Vet Intern Med       Date:  2016-09-26       Impact factor: 3.333

6.  An approach to quantifying abnormalities in energy expenditure and lean mass in metabolic disease.

Authors:  L P E Watson; P Raymond-Barker; C Moran; N Schoenmakers; C Mitchell; L Bluck; V K Chatterjee; D B Savage; P R Murgatroyd
Journal:  Eur J Clin Nutr       Date:  2013-11-27       Impact factor: 4.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.